A noteworthy trend in recent years has been the increase in the population based on age. Numerous chronic conditions, such as cancer, arthritis, chronic obstructive pulmonary disease (COPD), dementias, neurovascular disorders, and others, are more common among the elderly population. Older people are also more vulnerable to infections picked up in hospitals. Because many chronic diseases can affect this large group of senior individuals, using infection control measures during treatment is necessary. Because of this, the need for infection control solutions increases along with the global aged population, propelling the growth of the infection control market.

E-beam radiation, also known as beta irradiation, is widely used to sterilize medical equipment and pharmaceutical packaging materials. Low to medium density materials work best for this sterilization; very dense materials should not be used. It has the benefits of fast switch terminal sterilization and clean, straightforward on/off technology. Products can be sterilized using an e-beam for a brief period of time, so radiation compatibility problems cannot arise. E-beam sterilizing typically takes five to seven minutes to complete and minimizes handling and associated risks. Therefore, it is anticipated that during the course of the forecast period, the infection control market will grow significantly.

Nosocomial infections that happen during a patient’s stay in a hospital or other associated facility but are not noticed at the time of admission are known as hospital-acquired infections (HAIs). They are a leading global cause of illness and mortality. The majority of these infections are hospital-acquired pneumonia, bloodstream infections linked to central lines, surgical site infections, urinary tract infections linked to catheters, pneumonia linked to ventilators, and Clostridium difficile infections. The use of contaminated medical equipment during diagnostic and therapeutic operations is one of the main causes of HAIs.

Research Methodology:

After secondary research provided a fundamental understanding of the worldwide Infection Control Market scenario, extensive primary research was carried out. A number of primary interviews were carried out with industry experts from the supply and demand sides, including C- and D-level executives, product managers, and marketing and sales managers of major manufacturers, distributors, and channel partners from tier 1 and tier 2 companies offering Infection Control Market details, as well as personnel from academia, research, and CROs. These interviews were conducted across five major regions: North America, Europe, Asia Pacific, and the Rest of the World (Latin America & the Middle East & Africa). Participants from the supply-side and demand-side participated in about 70% and 30% of the primary interviews, respectively. Through the use of questionnaires, emails, online surveys, in-person interviews, and phone interviews, this main data was gathered. The primary participants share is given below:

Infection Control Market based on Type:

• Equipment
• Services
• Consumables
• Others

Infection Control Market based on End-use:

• Hospitals
• Medical Device Companies
• Clinical Laboratories
• Pharmaceutical Laboratories
• Others

Infection Control Market based on Geography:

• North America
  • US
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe (RoE)
• Asia Pacific (APAC)
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific (RoAPAC)
• Latin America (LATAM)
  • Brazil
  • Argentina
  • Rest of South America
• Middle East and Africa (MEA)
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

The global infection control market is divided into segments based on type: consumables, services, and equipment. In 2022, the consumables category held the biggest revenue share and dominated the infection control market. It is anticipated that consumables’ high market share will result from their short product life cycles and regular use. Consumables make up a bigger portion of the above-mentioned operations and are vital components that are widely used in sterilization, disinfection, and other control procedures. As of 2022, personal protective equipment accounted for a significant portion of consumables.

Moreover, sterilizing and disinfecting equipment is included in the equipment segment. Disinfectors are further divided into endoscope reprocesses, washers, and flushes once more. The sterilizing equipment is divided into five categories: liquid, radiation, heat, low-temperature, filtration, and sterilization by radiation. Additionally, consumables are divided into categories such as personal protective equipment, disinfectants, sterilizing consumables, and infectious waste disposal.

Many healthcare organizations are pushing for and raising awareness of the advantages of personal protection equipment, which is expected to account for a sizeable portion. The LEXA PLUS CLASS B sterilizer, for example, is a new, technologically advanced device that the W&H business added to its hygiene line to facilitate easier reprocessing and infection prevention for dental practice workflow.

Throughout the projected period, the services category is anticipated to develop at the fastest CAGR based on type. The market participants’ strong propensity to lower overall healthcare spending and benefit utilization is blamed for this quickest growth. Cost benefits, improved productivity, and a much greater emphasis on the key areas of development—which are vital to a business’s total growth and profit—are its main components. By releasing guidelines and recommendations for selection, risk assessment, sensible usage, removal, and other considerations to lower the risk of respiratory pathogen transmission to healthcare workers and other medical staff within a healthcare facility, the organizations also aim to promote adoption.

The global infection control market is divided into several segments based on the end-user, including clinical laboratories, pharmaceutical companies, hospitals, and medical device businesses. In addition to holding the biggest revenue share of around 40% in 2022 and dominating the infection control market, hospitals are predicted to grow at the fastest rate of 7.4% CAGR from 2023 to 2030. The significant portion is primarily due to the increased risk of contracting respiratory or blood-borne infections while on hospital property. Since hospital-acquired illnesses represent one of the biggest obstacles the market faces, strict control is necessary. Hospitals and public health groups have been pushed to implement extremely efficient control systems as a result.

With a revenue share of more than 30% in 2022, North America led the infection control market. This region’s significant market share has been attained through numerous strategic partnerships that major players in the industry have formed to expand their product offerings and infection control capabilities. Furthermore, the leading portion that North America has taken is the result of the established corporations’ increased efforts to expand throughout this region. As an example, Advanced Sterilization Products introduced the STERRAD 100NX System with ALLClear in the United States in January 2017 and intends to extend its reach throughout Europe, Africa, and the Middle East. A 510(k) clearance was granted to Advance Sterilization Products by the US Food and Drug Administration in 2020.

• This report illustrates the most vital attributes of the Infection Control Market, which are driving and providing opportunities.
• This research gives an in-depth analysis of the Infection Control Market growth on the basis of several segments in the market.
• This report presents the predictions of the past and present trends of the Infection Control Market.
• This study also presents the competitive analysis, such as key strategies and capabilities of major players of the Infection Control Market.